Critics warn that these restrictions may push some patients toward the illicit market for unregulated cannabis products.
Poland's Ministry of Health has recently implemented stringent regulations on medical cannabis prescriptions, now requiring in-person consultations and sidelining teleconsultations. This shift, aimed at combating potential abuse in the prescription system, significantly alters access for patients relying on cannabis-based therapies.
Alleged Teleconsultation Abuse Drives Policy Change
The Ministry of Health's decision follows a broader review of the e-prescription system. Health Minister Izabela Leszczyna explained that teleconsultations had opened the door to abuse, particularly with substances like opioids, according to Born2Invest. Although cannabis was not initially part of the measure, public consultations influenced its inclusion in the list of substances requiring in-person consultations.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out. Access Restrictions May Increase Illicit Cannabis Market Trade
While the ministry's move seeks to fortify patient safety and prescription integrity, it introduces substantial barriers for many. Patients suffering from chronic conditions, who found solace in the convenience and discretion of telemedicine, now face the challenge of securing in-person appointments. This is particularly daunting for those with limited mobility or residing in remote areas where specialist access is sparse.
The regulation may inadvertently nudge some patients towards the illicit market, as obtaining legal prescriptions becomes cumbersome. This shift not only risks patient safety due to unregulated products but also threatens to undermine the strides made in Poland's medical cannabis program by increasing illegal trade.
Read Also: Two European Marijuana Companies Team Up To Bring Cannabis-Based Solutions To Poland
Overly Restrictive Rules, Limited Clinics Worsen Access Issues
Critics and patient rights organizations have voiced concerns, suggesting that while the intent to safeguard the prescription process is valid, the method may be overly restrictive. They note that these new regulations could lead to a deterioration in care for those who rely on medical cannabis to manage various health conditions, especially those in remote areas or with limited mobility.
Moreover, experts warn that the number of stationary clinics offering medical cannabis treatments in Poland is limited, exacerbating the problem.
While the Ministry of Health aims to prevent abuse, it will be crucial to monitor the long-term effects of this decision and its impact on access to legal cannabis.
Read Next:
Poland Ministry Of Health Supports Decriminalizing Possession Of 25 Grams Of Cannabis, Cultivation Of 3 Plants
Image generated with AI tools.
Market News and Data brought to you by Benzinga APIs